NMRC Medical Trials Middle Gears up for Research to Advance Potential Influenza Prevention Remedy > United States Navy > News Tales

The research, anticipated to start in mid-April and funded by the Protection Well being Company, will consider SAb Biotherapeutics (SAB) remedy SAB-176, a novel infectious illness remedy designated by the U.S. Meals and Drug Administration

In accordance with the Facilities for Illness Management and Prevention, greater than 14,000,000 medical visits, 360,000 hospitalizations and 21,000 deaths occurred in the USA on account of influenza from 2022-2023. Influenza outbreaks can unfold simply amongst active-duty service members, particularly these residing in congregate settings, lowering mission readiness. A prevention possibility that may be administered remotely might cut back illness burden and optimize well being and operational readiness of Navy, Marine Corps and joint service personnel in all domains that will face a quickly transmitted infectious illness menace.

“You will need to assist research that advance therapeutics that may be feasibly delivered in a deployed setting,” defined Cmdr. Nehkonti Adams, director of NMRC CTC, and chief of the section 1 research. “This analysis might influence hundreds of lives, offering the capability to quickly reply to influenza and different infectious illnesses.”

“We stay up for evaluating SAB-176, and are excited to speed up NMRC efforts to boost warfighters readiness,” Adams added.

Comparable merchandise manufactured by SAB have been administered to over 700 wholesome volunteers and sufferers.

This research is open to all wholesome active-duty navy, dependents, retirees and WRNMMC personnel between the ages of 18 and 60. Contributors should not be pregnant, can not have acquired a flu shot up to now 90 days and should be capable of full at the very least eight visits to the CTC over the course of three months. Lively-duty personnel will likely be required to finish a supervisor’s approval kind. Contributors could also be eligible for compensation.

SAB Biotherapeutics is a clinical-stage biopharmaceutical firm centered on growing antibodies to fight micro organism and viruses, with out the necessity for human donors, to deal with and forestall immune and autoimmune problems.

NMRC CTC is situated at Naval Assist Exercise Bethesda, Constructing 17B (2nd ground). If you want to take part or have any questions, please contact the middle at 301-295-4735 (name) or 301-233-9640 (textual content), or by way of e-mail at usn.nmrc.ctc@well being.mil to schedule an appointment.

The CTC evaluates vaccines, therapeutics, prophylactics and medical units in human topics to advance merchandise from the laboratory to the entrance line and maximize the medical readiness of the warfighter.

Story initially posted on DVIDS: NMRC Medical Trials Middle Gears up for Research to Advance Potential Influenza Prevention Remedy